Similarly, Liu et al [19] reported that CD133+ glioblastoma cells treated with multiple chemotherapeutic agents had fewer deaths than their CD133− counterparts as a result of overexpression of anti-apoptotic genes such as FLIP, Bcl-2, and Bcl-XL. This evidence concerns the gene PROM1 and glioblastoma.